| 主权项 |
1. A method for treating a patient in need of treatment with an antibiotic, an anti-inflammatory agent, or a contrast medium, comprising:
obtaining a biological sample from the patient; measuring expression level of at least one kidney risk factor (KRF) in the sample, wherein the KRF is selected from the group consisting of VCAN, NRP1, CCL2, CCL19, COL3A1 and GZMM; detecting upregulation of the KRF in the biological sample with respect to one or more control samples obtained from subjects without acute kidney injury disease; and administering an antibiotic other than an aminoglycoside antibiotic, an anti-inflammatory agent other than an NSAID, or a contrast medium other than an iodinated contrast medium to the patient when upregulation of the KRF is detected in the biological sample. |
